@Mike182035 Hi Mike
"Not a prediction – just a way to visualise."
A comparison with another company having similarities with #AVCT with regards to clinical stages.
My view - based on RNS so far - nothing at this stage to stress.
What is your view of reality?
Just a thought.
Prometheus vs Avacta on a comparable value-inflection timeline.
Prometheus was acquired ~4 months after clear Phase 2 efficacy.
AVA6000 approaching a similar decision window in 2026.
Not a prediction – just a way to visualise.
#AVCT#AVACTA#Biotech